Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anton A. Pushkin"'
Autor:
Oleg I. Kit, Anton A. Pushkin, Ilya A. Alliluyev, Nataliya N. Timoshkina, Dmitry Y. Gvaldin, Eduard E. Rostorguev, Nataliya S. Kuznetsova
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Highly malignant high-grade gliomas are tumors of the central nervous system (CNS). They are solid tumors arising from transformed cells of the brain and/or the spinal cord. In recent years, the expression of genes and regulating
Externí odkaz:
https://doaj.org/article/beb1bc9dca894989a497050b191245c9
Autor:
Dmitry Y. Gvaldin, Anton A. Pushkin, Nataliya N. Timoshkina, Eduard E. Rostorguev, Arbi M. Nalgiev, Oleg I. Kit
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 21, Iss 1, Pp 1-17 (2020)
Abstract Background The purpose of this study was to characterize subtype-specific patterns of mRNA and miRNA expression of gliomas using The Cancer Genome Atlas (TCGA) data to search for genetic determinants that predict prognosis in terms of overal
Externí odkaz:
https://doaj.org/article/39f3313a194e4fd1a7cde6d9f12a3e3e
Autor:
Anton A. Pushkin, Yuriy E. Burda, Aleksandr A. Sevast’yanov, Vladimir F. Kulikovskiy, Svetlana Yu. Burda, Polina A. Golubinskaya, Alina K. Zvyagina, Natal’ya V. Kulyushina
Publikováno v:
Research Results in Pharmacology, Vol 4, Iss 1, Pp 17-25 (2018)
Today, considerable progress in the renal cell carcinoma (RCC) treatment has been made due to development of targeted and immunotherapeutic approaches to the RCC treatment, especially in metastasising carcinoma. In the early stages of RCC, it is poss
Externí odkaz:
https://doaj.org/article/d0c01a6e20a8419c9b2d57647f78cd7c
Autor:
Oleg Kit, Olga Sergeevna Shlyk, Larisa Vashchenko, Irina Dashkova, Natalya Nikolaevna Timoshkina, Anton Andreevich Pushkin, Vladislavovna Zaikina Ekaterina, Elena Nikolaevna Chernikova
Publikováno v:
Medical news of the North Caucasus. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eacb86fff0d29c6990fa8ce9ef353ee4
https://doi.org/10.14300/mnnc.2022.17011
https://doi.org/10.14300/mnnc.2022.17011
Autor:
Anton A. Pushkin, Eduard E. Rostorguev, Sergey E. Kavitskiy, Elena A. Dzhenkova, Oleg I. Kit, Marina A. Engibaryan, Vladimir N. Kasyanenko
Publikováno v:
Journal of Clinical Oncology. 40:e14027-e14027
e14027 Background: Circulating microRNAs (miRNAs) are currently being investigated as non-invasive diagnostic biomarkers in a wide range of tumors. However, there is still no sufficiently reliable siRNA signature for routine screening of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93311a2ce1f354632176b01392ec5ae7
https://doi.org/10.1200/jco.2022.40.16_suppl.e14027
https://doi.org/10.1200/jco.2022.40.16_suppl.e14027
Autor:
Oleg I. Kit, Anton A. Pushkin, Dmitry Yu. Gvaldin, Inna A. Novikova, Natalya N. Timoshkina, Natalya V. Soldatkina, Yuriy A. Gevorkyan, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15500-e15500
e15500 Background: The immune response plays a key role in the oncogenesis of colorectal cancer. The heterogeneity of the tumor environment determines the need for immunogenetic profiling to identify associations with the implementation of tumor-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39dbc236f395ee124e262bb7a5285e34
https://doi.org/10.1200/jco.2022.40.16_suppl.e15500
https://doi.org/10.1200/jco.2022.40.16_suppl.e15500
Autor:
Inna A. Novikova, Elena Yu Zlatnik, Dmitry Yu. Gvaldin, Anton A. Pushkin, Yuriy A. Gevorkyan, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Oleg Yu. Kaymakchi, Oleg I. Kit, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15502-e15502
e15502 Background: The purpose of this study was a comparative analysis of the expression of miRNAs in the tumor and circulating tumor cells (CTCs) in colon cancer (CC). Methods: Expression of seven miRNAs (hsa-let-7i-5p, hsa-miR-126-5p, hsa-miR-143-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd80dcb37e51c875d00c28676bf74c05
https://doi.org/10.1200/jco.2022.40.16_suppl.e15502
https://doi.org/10.1200/jco.2022.40.16_suppl.e15502
Autor:
Arbi M. Nalgiev, Oleg I. Kit, Eduard E. Rostorguev, Nataliya N. Timoshkina, Anton A. Pushkin, Dmitry Yu. Gvaldin
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 21, Iss 1, Pp 1-17 (2020)
Background The purpose of this study was to characterize subtype-specific patterns of mRNA and miRNA expression of gliomas using The Cancer Genome Atlas (TCGA) data to search for genetic determinants that predict prognosis in terms of overall surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276da957a3046898289e090a88278e62
https://doi.org/10.1186/s43042-020-00119-8
https://doi.org/10.1186/s43042-020-00119-8
Autor:
Eduard E. Rostorguev, Elena Yurievna Zlatnik, Oksana G. Shulgina, A.B. Sagakyants, Natalia Soldatkina, Sergey N. Ignatov, Anton A. Pushkin
Publikováno v:
Neuroscience for Medicine and Psychology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7a5473cb3ac169a60c8c925216a446d
https://doi.org/10.29003/m1061.sudak.ns2020-16/222-223
https://doi.org/10.29003/m1061.sudak.ns2020-16/222-223
Autor:
Yuriy E. Burda, Natal’ya V. Kulyushina, Svetlana Y. Burda, Anton A. Pushkin, Alina K. Zvyagina, Vladimir F. Kulikovskiy, Polina A. Golubinskaya, Aleksandr A. Sevast’yanov
Publikováno v:
Research Results in Pharmacology, Vol 4, Iss 1, Pp 17-25 (2018)
Research Results in Pharmacology 4(1): 17-25
Research Results in Pharmacology 4(1): 17-25
Today, considerable progress in the renal cell carcinoma (RCC) treatment has been made due to development of targeted and immunotherapeutic approaches to the RCC treatment, especially in metastasising carcinoma. In the early stages of RCC, it is poss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ed2964b251862705adf34bade18645
https://rrpharmacology.pensoft.net/article/25251/download/pdf/
https://rrpharmacology.pensoft.net/article/25251/download/pdf/